IP Library › Granted Patent US 11,123,432
Granted Patent B2
US 11,123,432 · App. 16/463,407 · Granted Sep 21, 2021

Antimicrobial insect repellent composition

Inventors: Fikrettin Sahin (Istanbul, TR); Zeynep Iyigundogdu (Istanbul, TR); Okan Demir (Istanbul, TR); Sadik Kalayci (Istanbul, TR); Binnur Kiratli (Istanbul, TR)
Assignee: YEDITEPE UNIVERSITESI
A61K47/10A01N25/22A01N37/18A01N59/00A01N59/14A61K31/221A61K33/22A61K33/40A61P31/04A61P31/10A61P31/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,432
App. No.
16/463,407
Granted
Sep 21, 2021
Kind
B2
Abstract

An antimicrobial (anticandidal, antibacterial, antifungal) and antiviral composition which repels insects such as flies, mosquitoes and ticks. The composition includes poloxamer, boron compound, ethyl butyl acetylaminopropionate and preferably hydrogen peroxide. The present composition is a composition which can be applied in different forms via oral, nasal, ophthalmic, otic, local, ventricle, vaginal, rectal, dermal, intravenous, intramuscular, subcutaneous and intradermal route.

Claims (7)

1. An insect repellent composition, comprising poloxamer, a boron compound, ethyl butyl acetylaminopropionate and 1% (w/w) hydrogen peroxide, wherein the poloxamer is 5-15% (w/w), the boron compound is 1-5% (w/w), the ethyl butyl acetylaminopropionate is 15-25% (w/w), and the boron compound is sodium borate,

wherein, the insect repellant composition is antimicrobial and antiviral, and the insect repellant composition exhibits antifungal activity on the fungi Aspergillus niger, Botrytis cinerea, Fusarium oxysporum and Penicillium vinaceum , and antimicrobial activity on VRE.

2. The insect repellent composition according to claim 1 , wherein, the insect repellant composition exhibits antimicrobial activity on the bacteria Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Bacillus subtilis, Acinetobacter baumannii , and MRSA.

3. The insect repellent composition according to claim 1 , wherein, the insect repellant composition exhibits anticandidal activity on the yeast Candida albicans.

4. The insect repellent composition according to claim 1 , wherein, the insect repellant composition has antiviral activity against enveloped and non-enveloped DNA and RNA viruses.

5. The insect repellent composition according to claim 4 , wherein, the insect repellant composition is in a form of tablets, capsules, pastilles, drops, syrups, suppositories, gels, lotions, ampoules, or tubes.

6. The insect repellent composition according to claim 5 , wherein, the insect repellant composition is configured to be applied via oral, nasal, ophthalmic, otic, local, ventricle, vaginal, rectal, dermal, intravenous, intramuscular, subcutaneous or intradermal route.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2019
From: SAHIN, FIKRETTIN; IYIGUNDOGDU, ZEYNEP; DEMIR, OKAN; KALAYCI, SADIK; KIRATLI, BINNUR
To: YEDITEPE UNIVERSITESI
Reel/Frame 049509/0512 →
Priority Claims (1)
TR 2016/17080 · Nov 23, 2016 · national
Continuity (1)
Related Publication 20190351059A1 · Nov 21, 2019
Cited By (2)
US 12,281,239 US 12,521,413